Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of inhaled apomorphine for motor fluctuations in Parkinson's disease
2008-004447-11Phase 2Completed
- Sponsor
- Vectura
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of apomorphine in Parkinson's disease (PD) (5 arms), sponsored by Vectura. Primary endpoints: Change in daily off time and Maximum change in UPDRS Part III score. Started Oct 2008; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2008-004447-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004447-11.